Award Sub-Category: Cancer Diagnostics and Treatment Technologies

SCINTIX therapy is designed to treat all stages of cancer, providing a
new treatment for metastatic disease. It’s the first therapy to use
signals produced by the cancer itself to autonomously guide treatment,
even for tumors that are moving. SCINTIX expands radiotherapy from
single-tumor to multiple-tumors and reduces radiation to healthy tissue.

The HrC Test is a blood test that assesses the risk of cancer presence
or absence. It can detect all types of cancer in a single test with 93%
sensitivity, and can detect it before a tumor has formed. It is also a
prognostic test that can rule out the risk of cancer for the next 12
months. We can make cancer an early-stage, treatable disease.